含硅二烃基锡羧酸酯的合成及抗癌活性

采用含硅二烃基锡氧化物和羧酸,以1∶2物质量的比进行反应,合成了5个新的有机锡化合物——含硅二烃基锡羧酸酯R(Me_3SiCH_2)SnL_2(R=Me_3SiCH_2或n-Bu,Cy;HL为1-金刚烷甲酸或N-乙酰甘氨酸)。通过IR、~1H NMR、~(13)C NMR和元素分析对它们的结构进行了表征;生物活性测定初步结果表明,它们对乳腺癌细胞MDA-MB-231具有较好的体外抗癌活性。     

二溴苯基萤光酮光度法测定铜合金中锡

用自制二溴苯基萤光酮(DBPF)对铜合金中锡的测定进行了试验。于pH2.2盐酸-氯化钾缓冲液的50毫升显色液中,存在10毫升乙醇、2毫升3×10~(-4)MDBPF溶液、1毫升0.1%CPB乙醇(2+3)溶液所形成的锡-DBPF-CPB三元络合物,15分钟后显色完全,并可稳定80分钟;0—25微克/50毫升锡范围符合比尔定律。对10微克锡,用1毫升混合掩蔽剂     

Pt—Re—Sn—K／Al2O3系催化剂的穆斯堡尔谱研究

应用~(119m)Sn穆斯堡尔谱考察了Pt-Re-Sn-K/Al_2O_3系脱氢催化剂,获得了组成相同制法不同的Pt-Re-Sn-K/Al_2O_3系催化剂上各种锡物类的信息,以及Pt、Re、Sn之间的相互作用对生成锡物类的影响。实验表明,Pt-Sn/Al_2O_3催化剂中由于Pt、Sn的相互作用,生成了一定构型的Pt_xSn_y原子簇,其生成的难易与Pt、Sn间相互作用的强弱有关,而Re-Sn/Al_2O_3催化剂中由于Re、Sn间的相互作用较弱,因此该类催化剂上仅有四价(SnO_2)和二价锡(SnO)物类,在Pt-Re-Sn-Al_2O_3催化剂上,由于Re的存在对Pt、Sn间的相互作用有一定影响,故影响着生成的Pt_xSn_y原子簇的结构与性能。     

二{氧合—二[2—呋喃甲酸二苄基锡（IV）]}的合成、性质及晶体结构

以二苄基氧化锡和2-呋喃基羧酸反应，合成了新的化合物二[氧合-二[2—呋喃甲酸二苄基锡(IV)]}．生物活性测试结果表明，该配合物具有较强的体外抗癌活性．X射线单晶衍射测定表明，配合物是以Sn2O2四元环为中心的、中心对称的二聚体结构，内环锡为六配位的畸变八面体结构，外环锡为五配位的加帽畸变三角双锥结构．     

二苄基一氯化锡氨荒酸酯的合成与表征

合成了13个新的二苄基一氯化锡氨荒酸酯化合物(PhCH~2)~2Sn(Cl)Sn(Cl)S~2CNRR'。利用元素分析、UV、IR、^1HNMR谱和TG-DTA表征了它们的结构。初步生物活性研究表明,有些化合物表现出体外抑制白血细胞P~3~8~8生长的活性。     

三个二(有机锡)吡啶-2,3(5)-二甲酸酯的合成、结构和体外抗癌活性

在微波溶剂热中,三环已基氢氧化锡、氧化双(三((2-甲基-2-苯基)丙基)锡)与吡啶-2,3(5)-二甲酸反应,合成了3个双核二(有机锡)吡啶-2,3(5)-二甲酸酯:Py(CO)_2(SnR_3)_2(MeOH)_n(R:Cy,n=1(1),2(2);R:PhCMe_2CH_2,n=0(3)),对它们的组成和结构进行了元素分析、IR、(~1H,~(13)C,~(119)Sn)NMR和X射线晶体衍射分析表征,化合物中心锡与配基原子构成畸形四/六面体构型,由于氢键作用,化合物1形成一维链,2形成二维34元大环网状结构。化合物对人结肠癌(HT-29)、肝癌细胞(HepG2)、乳腺癌(MCF-7)、鼻咽癌(KB)和肺癌细胞(A549)的增殖有较强的抑制作用。     

三环己基锡O,O‘—二（4—氯苯基）—二硫代磷酯酯和二丁基锡双（O,O’—二…

三环己基锡Ｏ，Ｏ’－二（４－氯苯基）二硫代磷酸酯（Ｉ），Ｃ３０Ｈ４１Ｃｌ２（Ｏ２ＰＳ２Ｓｎ，Ｍｒ＝７１８．３６，单斜晶系，Ｐ２１／ｎ，ａ＝１６．１５１（２），ｂ＝９．４１５９（１），ｃ＝２２．９８７（３），Ａ，β＝１０５．６９（１）°，Ｚ＝４，Ｄｃ＝１．４１８ｇ．ｃｍ＾－３，Ｒ＝０．０６３；二丁基锡双（Ｏ，Ｏ’－二（４－甲基苯基）二硫代磷酯酯（Ⅱ），Ｃ３６Ｈ４６Ｏ４Ｐ２Ｓ４Ｓｎ，Ｍｒ＝８５１．６６     

双(二苄基锡杂环羧酸酯)氧化物的合成与表征

通过二苄基氧化锡与杂环取代羧酸反应,合成了8种新的双(二苄基锡杂环羧酸酯)氧化物{[(PhCH~2)~2SnO~2CR]~2O}~2(R=2-呋喃基,2-呋喃乙烯基,2-噻吩基,3-吡啶基,4-吡啶基,2-吡啶基,3-吲哚甲基,3-吲哚丙基)。生物活性测试表明,部分化合物具有一定的抗癌活性。     

二苄基锡N,N-二甲基氨荒酸酯的合成及晶体结构

利用二苄基二氯化锡和N, N-二甲基氨荒酸钠反应, 合成了二苄基锡N, N-二甲基氨荒酸酯(C20H26N2S4Sn, Mr = 541.36)。通过元素分析、红外光谱、核磁共振氢谱和质谱对其结构进行了表征。用X-射线单晶衍射测定了该化合物的晶体结构。化合物为单斜晶系, 空间群P21/n, a = 1.3926(5), b = 0.9832(4), c = 1.7080(7) nm, b = 103.541(6), V = 2.274(2) nm3, Z = 4, Dc = 1.581 g/cm3, m(MoKa) = 1.500 mm-1, F(000) = 1096, R = 0.0482, wR = 0.1162. 在化合物的晶体中, 锡原子为六配位的畸变八面体构型。     

钒试剂(2,2′—二羧基二苯胺)分光光度法测定三氧化钨中微量钒

本文试验了在醋酸缓冲液介质中,以少量锡(Ⅱ)作戴体,用铜试剂-氯仿萃取分离钨中微量釩的条件,经萃取分离获得的釩于20N硫酸介质中用2,2′-二2羧基二苯胺显色,于610毫微米处,进行光度测定。釩在5—50微克/25毫升范围内服从比耳定律,测定灵敏度为0.08微克/毫升。50毫克锡(Ⅳ)、1毫克钼(Ⅵ),500微克铜(Ⅱ)、镍(Ⅱ)、钴(Ⅱ)、铁(Ⅲ)不干扰。铬、铈等干扰,可在萃取时分离之。氧化还原性物质干扰,如过氯酸、硝酸等必须事先用硫酸冒烟赶尽。本法可测定三氧化钨中0.0005—0.03％釩,相对误差为±7—±12％,手续简便、快速。     

Studies on Tricyclohexyltin ( Ⅳ ) Diaryldithiophosphates

Fourteen new tricyclohexyltin (Ⅳ)-O,O-diaryldithiophosphates were synthesized and determined by IR, 1H NMR, 13C NMR, 119Sn NMR MS, and elemental analysis. The structures of all the compounds consist of discrete molecule containing a four-coordinated tin atom. Results from the preliminary biological test show that these compounds have a high miticidal activity.     

Use of 13C NMR spectrometric data to produce a predictive model of estrogen receptor binding activity

We have developed a spectroscopic data-activity relationship (SDAR) model based on 13C NMR spectral data for 30 estrogenic chemicals whose relative binding affinities (RBA) are available for the alpha (ERalpha) and beta (ERbeta) estrogen receptors. The SDAR models segregated the 30 compounds into strong and medium binding affinities. The SDAR model gave a leave-one-out (LOO) cross-validation of 90%. Two compounds that were classified incorrectly in the SDAR model were in the transition zone between classifications. Real and predicted 13C NMR chemical shifts were used with test compounds to evaluate the predictive behavior of the SDAR model. The 13C NMR SDAR model using predicted 13C NMR data for the test compounds provides a rapid, reliable, and simple way to screen whether a compound binds to the estrogen receptors.     

NMR spectroscopic analysis of new spiro-piperidylrifamycins

New spiro-piperidylrifamycin derivatives are presented. These compounds were synthesized from the reaction of 3-amino-4-iminorifamycin S and enantiomerically pure 4-piperidones, which generate diasteroisomeric rifabutin analogues with a new stereocentre at the spiranic carbon. The (1)H and (13)C NMR spectra of these new compounds, and also the configuration of the new stereogenic centres, were assigned using 2D NMR spectroscopic techniques. A preliminary study of the (1)H and (13)C NMR spectra of the starting compounds rifamycin S, 3-amino-4-iminorifamycin S and the related rifabutin was also carried out and as a result, their previously published (13)C NMR data were corrected.     

Studies on the Syntheses and Biological Activities of 3-Aryl-6-(1,1'-biphenyl-4-yl)-7H-1,2,4-triazolo[3,4-b][1,3,4]thiadiazines

IntroductionAmongst various heterocycles 3 ,6 -disubstituted- 7H- 1 ,2 ,4- triazolo[3 ,4- b][1 ,3 ,4]thiadiazines have received considerable attentionduring the lasttwo decades as potentially biologicalactive agents[1,2 ] . A literature survey indicated thatthis kind of N - bridged heterocycles displayed awide spectrum of biological properties,such asantimicrobial[3] ,antibacterial,antifungal[4 ] ,antiinflammatory[5] ,diuretic[6 ] ,anthelmintic,andanalgesic[7] . They can also be used as the p…     

新型1,2,3-三唑类化合物的合成及抗菌构效关系

根据活性基团拼接原理, 以4-取代-苯胺为原料, 经重氮化、 关环和缩合反应合成了17个化合物1-(4-取代苯基)-5-取代苯基亚氨基-4-取代-1,2,3-三唑(7a~7c和13a~13d)和1-(4-取代苯基)-5-取代苄基氨基-4-取代-1,2,3-三唑(5a~5c, 10a~10c和14a~14d), 其中化合物5a~5c, 7b, 7c, 10a, 10c, 13b~13d和14b~14c为新化合物, 对所制备化合物的结构进行了表征. 生物活性测试结果表明, 所有化合物均表现出一定的抑菌活性, 对大肠杆菌的抑菌活性均优于氟康唑; 化合物7a和10c对金黄色葡萄球菌的抑制活性明显优于氟康唑; 而化合物13a和13d则对白色念球菌表现出良好的抑制活性, 与三氯生相当.     

Synthesis and activities of new 4-hydroxy benzoxazolone derivatives

<正>A series of new 4-substituted benzoxazolone derivatives were synthesized according to a convenient method,their anti-inflammatory and analgesic activities in vivo were evaluated.All of them were new compounds,the structures of all the synthesized compounds were confirmed by ~1H NMR,~(13)C NMR,ESI-MS and HR-MS.Most of the compounds exhibited anti-inflammatory activity.     

Producing 13C NMR, infrared absorption, and electron ionization mass spectrometric data models of the monodechlorination of chlorobenzenes, chlorophenols, and chloroanilines

We have developed four spectroscopic data-activity relationship (SDAR) models of monodechlorination of 32 chlorinated benzene compounds in anaerobic estuarine sediment. The SDAR models were based on combinations of 13C nuclear magnetic resonance (NMR), infrared absorption (IR), and electron ionization mass spectrometric (EI MS) data. The SDAR models segregated the 32 compounds into 17 readily monodechlorinated compounds and 15 not readily monodechlorinated compounds. The SDAR model based on 13C NMR, IR, and EI MS data gave a leave-one-out cross-validation of 93.8%. The SDAR model based on a composite of 13C NMR and IR data gave a leave-one-out cross-validation of 90.6%. The SDAR model based on a composite of IR and EI MS data gave a leave-one-out cross-validation of 84.4%. The SDAR model based on a composite of 13C NMR and EI MS data gave a leave-one-out cross-validation of 84.4%. These reliable SDAR models provide a rapid and simple way to predict whether a chlorinated benzene compound will readily go through monodechlorination. The FDA has filed a patent application on methods of using any combination of spectral data (NMR, MS, UV-vis, IR, and fluorescence, phosphorescence) to model a chemical, physical, or biological endpoint.     

双酰胺类衍生物的合成及抑菌活性

以对氯苯甲酸和取代邻氨基苯甲酸为起始原料,设计并合成9个未见文献报道的含苯并噻唑基双酰胺类化合物,其结构经1H NMR、13C NMR、IR及元素分析确证。初步生物活性测试结果表明,部份化合物具有一定的抑菌活性。     

三苯基锡芳氧乙酸酯的合成和表征

三苯基锡芳氧乙酸酯的合成和表征刘宝殿，包明，张景萍（东北师范大学化学系、东北师范大学分析测试中心，长春，１３００２４）关键词芳氧乙酸，三苯基锡芳氧乙酸酯，合成，生物活性三苯基醋酸锡和三苯基氢氧化锡是防治甜菜褐斑病的有效药剂［１］．芳氧乙酸及其酯也具有...     

Synthesis and Evaluation of Some New (1,2,4) Triazolo(4,3‐a)Quinoxalin‐4(5H)‐one Derivatives as AMPA Receptor Antagonists

This study involves the synthesis and anticonvulsant evaluation of 1‐ethyl‐3‐hydrazinylquinoxaline‐2‐(1H)‐one ( 8 ), its chemical confirmations 9 and 10 and certain (1,2,4) triazolo(4,3‐a)quinoxalin‐4(5H)‐one compounds 11 , 12 , 13 , 13a , 13b , 13c , 13d , 13e , 13f , 14 , 15 , 16 . The structure of the synthesized compounds was confirmed chemically by elemental analyses and spectral data (IR, ¹H NMR, ¹³C NMR, and Mass). Docking studies were preformed to all of the synthesized compounds to predict, in a qualitative way, the anticonvulsant activity of the proposed compounds. There is a promising correlation between the results of molecular modeling and the anticonvulsant activity of the synthesized compounds. The highest fitting value was noticed for compounds 9 and 10 , which showed the highest anticonvulsant activity.